Ambrisentan
CAS: 177036-94-1
Ref. TM-T1655
| 5mg | 59.00 € | ||
| 10mg | 73.00 € | ||
| 25mg | 118.00 € | ||
| 50mg | 171.00 € | ||
| 100mg | 248.00 € | ||
| 500mg | 611.00 € | ||
| 1ml*10 (DMSO) | 68.00 € |
Estimated delivery in United States, on Thursday 16 May 2024
Product Information
Name:
Ambrisentan
Synonyms:
- BSF-208075, BSF 208075, LU 208075
- (2S)-2-[(4,6-Dimethylpyrimidin-2-Yl)Oxy]-3-Methoxy-3,3-Diphenylpropanoic Acid
- (As)-A-[(4,6-Dimethyl-2-Pyrimidinyl)Oxy]--Methoxy--Phenylbenzenepropanoic Acid
- (αS)-α-[(4,6-Dimethyl-2-pyrimidinyl)oxy]-β-methoxy-β-phenylbenzenepropanoic acid
- 2-(4,6-Dimethylpyrimidin-2-Yl)Oxy-3-Methoxy-3,3-Di(Phenyl)Propanoic Acid
- Benzenepropanoic acid, α-[(4,6-dimethyl-2-pyrimidinyl)oxy]-β-methoxy-β-phenyl-, (S)-
- Benzenepropanoic acid, α-[(4,6-dimethyl-2-pyrimidinyl)oxy]-β-methoxy-β-phenyl-, (αS)-
- Bsf 208075
- Bsf 208075,(+)-(2S)-2-[(4,6-Dimethylpyrimidin-2-Yl)Oxy]-3-Methoxy-3,3-Diphenylpropanoic Acid
- Letairis
- See more synonyms
- Lu 208075
- Volibris
CAS:
Description:
Ambrisentan (BSF 208075) is an endothelin receptor antagonist used in the therapy of pulmonary arterial hypertension (PAH). Ambrisentan has been associated with a low rate of serum enzyme elevations during therapy but has yet to be implicated in cases of clinically apparent acute liver injury.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
378.42
Formula:
C22H22N2O4
Purity:
99.85%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T1655 Ambrisentan
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
